Multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution
- PMID: 34480159
- DOI: 10.1038/s41592-021-01242-z
Multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution
Abstract
N6-methyladenosine (m6A) is the most prevalent modification of messenger RNA in mammals. To interrogate its functions and dynamics, there is a critical need to quantify m6A at three levels: site, gene and sample. Current approaches address these needs in a limited manner. Here we develop m6A-seq2, relying on multiplexed m6A-immunoprecipitation of barcoded and pooled samples. m6A-seq2 allows a big increase in throughput while reducing technical variability, requirements of input material and cost. m6A-seq2 is furthermore uniquely capable of providing sample-level relative quantitations of m6A, serving as an orthogonal alternative to mass spectrometry-based approaches. Finally, we develop a computational approach for gene-level quantitation of m6A. We demonstrate that using this metric, roughly 30% of the variability in RNA half life in mouse embryonic stem cells can be explained, establishing m6A as a main driver of RNA stability. m6A-seq2 thus provides an experimental and analytic framework for dissecting m6A-mediated regulation at three different levels.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.
Similar articles
-
METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.Cell Biol Int. 2020 Dec;44(12):2524-2531. doi: 10.1002/cbin.11459. Epub 2020 Sep 11. Cell Biol Int. 2020. PMID: 32869897
-
Transient N-6-Methyladenosine Transcriptome Sequencing Reveals a Regulatory Role of m6A in Splicing Efficiency.Cell Rep. 2018 Jun 19;23(12):3429-3437. doi: 10.1016/j.celrep.2018.05.077. Cell Rep. 2018. PMID: 29924987
-
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.Mol Cancer. 2019 Aug 22;18(1):127. doi: 10.1186/s12943-019-1053-8. Mol Cancer. 2019. PMID: 31438961 Free PMC article.
-
Physio-pathological effects of m6A modification and its potential contribution to melanoma.Clin Transl Oncol. 2021 Nov;23(11):2269-2279. doi: 10.1007/s12094-021-02644-3. Epub 2021 Jun 8. Clin Transl Oncol. 2021. PMID: 34105069 Free PMC article. Review.
-
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.J Hematol Oncol. 2021 Jul 27;14(1):117. doi: 10.1186/s13045-021-01129-8. J Hematol Oncol. 2021. PMID: 34315512 Free PMC article. Review.
Cited by
-
Exploring the epitranscriptome by native RNA sequencing.RNA. 2022 Nov;28(11):1430-1439. doi: 10.1261/rna.079404.122. Epub 2022 Sep 14. RNA. 2022. PMID: 36104106 Free PMC article.
-
N6-methyladenosine in 5' UTR does not promote translation initiation.Mol Cell. 2024 Feb 1;84(3):584-595.e6. doi: 10.1016/j.molcel.2023.12.028. Epub 2024 Jan 19. Mol Cell. 2024. PMID: 38244546
-
Detection, regulation, and functions of RNA N6-methyladenosine modification in plants.Plant Commun. 2023 May 8;4(3):100546. doi: 10.1016/j.xplc.2023.100546. Epub 2023 Jan 10. Plant Commun. 2023. PMID: 36627844 Free PMC article. Review.
-
scm6A-seq reveals single-cell landscapes of the dynamic m6A during oocyte maturation and early embryonic development.Nat Commun. 2023 Jan 19;14(1):315. doi: 10.1038/s41467-023-35958-7. Nat Commun. 2023. PMID: 36658155 Free PMC article.
-
Alphaherpesvirus-mediated remodeling of the cellular transcriptome results in depletion of m6A-containing transcripts.iScience. 2023 Jul 10;26(8):107310. doi: 10.1016/j.isci.2023.107310. eCollection 2023 Aug 18. iScience. 2023. PMID: 37575180 Free PMC article.
References
-
- Perry, R. P. & Kelley, D. E. Existence of methylated messenger RNA in mouse L cells. Cell 1, 37–42 (1974). - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
